Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot Q99674: Variant p.Gly243Glu

Cell growth regulator with EF hand domain protein 1
Gene: CGREF1
Feedback?
Variant information Variant position: help 243 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LB/B The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change: help From Glycine (G) to Glutamate (E) at position 243 (G243E, p.Gly243Glu). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from glycine (G) to medium size and acidic (E) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help -2 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Polymorphism: help The number of repeats of 17 amino acids in the C-terminal is polymorphic and varies between 3 and 4. The majority of available transcripts lacks one of these repeats. The sequence shown, corresponding to the reference genome (GRCh38/hg38), contains 4 repeats. Additional information on the polymorphism described.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 243 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 318 The length of the canonical sequence.
Location on the sequence: help GEAEGQAEAKGDAPGPRGEA G GQAEAEGDAPGPRGEAGGQA The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human                         GEAEGQAEAKGDAPGPRGEAGGQAEAEGDAPGPRGEAGGQA

Mouse                         ------------------EAGHQTEGKVDTLSPEEEARGQA

Rat                           ------------------EAGHHIETKVDALSPEGEARGQA

Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 20 – 318 Cell growth regulator with EF hand domain protein 1
Repeat 236 – 252 2
Region 177 – 318 Disordered
Region 219 – 286 4 X 17 AA approximate tandem repeats of P-G-P-R-G-E-A-G-G-Q-A-E-A-[KR]-G-D-A
Alternative sequence 133 – 318 Missing. In isoform 2.
Alternative sequence 209 – 318 Missing. In isoform 3.



Literature citations
Induction of cell growth regulatory genes by p53.
Madden S.L.; Galella E.A.; Riley D.; Bertelsen A.H.; Beaudry G.A.;
Cancer Res. 56:5384-5390(1996)
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 4); VARIANTS GLU-243 AND 253-ALA--GLU-269 DEL; INDUCTION BY TP53;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.